| DIRECT COMPETITOR COMPARISON | |
| AMLN | GSK | MRK | NVO | Industry | | Market Cap: | 1.94B | 108.50B | 77.28B | 39.22B | 97.43M | | Employees: | 1,800 | 99,003 | 55,200 | 28,497 | 65 | | Qtrly Rev Growth (yoy): | -3.30% | 14.90% | 1.80% | 11.30% | 19.70% | | Revenue (ttm): | 816.77M | 45.19B | 23.37B | 10.18B | 14.05M | | Gross Margin (ttm): | 59.56% | 76.27% | 76.36% | 79.57% | 63.92% | | EBITDA (ttm): | -125.22M | 17.81B | 7.81B | 3.51B | -12.30M | | Oper Margins (ttm): | -19.59% | 34.30% | 26.63% | 29.92% | -124.89% | | Net Income (ttm): | -234.68M | 8.12B | 8.05B | 2.17B | N/A | | EPS (ttm): | -1.680 | 3.18 | 3.808 | 3.56 | -0.32 | | P/E (ttm): | N/A | 13.46 | 9.62 | 18.47 | 16.41 | | PEG (5 yr expected): | N/A | 3.01 | 2.09 | 1.19 | 1.31 | | P/S (ttm): | 2.30 | 2.37 | 3.27 | 3.82 | 9.54 |
|
| GSK = GlaxoSmithKline plc | | MRK = Merck & Co. Inc. | | NVO = Novo Nordisk A/S | | Industry = Biotechnology | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.38 | 1.02% | 58.08B | 12.51 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.37 | -0.02% | 13.70B | 15.85 | | Genzyme Corp. | GENZ | 51.00 | 1.23% | 13.53B | 29.08 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.90 | -0.13% | 42.21B | 18.14 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.92 | 1.47% | 9.08B | 1039.18 | | Teva Pharmaceutical Industries Limited | TEVA | 53.11 | -0.30% | 46.79B | 48.59 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.58 | 1.43% | 3.99B | 19.37 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.04 | -0.33% | 2.99B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.37 | 0.38% | 5.61B | 112.70 | | Pfizer Inc. | PFE | 18.47 | 0.87% | 149.04B | 15.34 | | Johnson & Johnson | JNJ | 63.35 | 0.27% | 174.79B | 13.83 | | GlaxoSmithKline plc | GSK | 42.80 | 1.23% | 108.50B | 13.46 | | Sanofi-Aventis | SNY | 39.41 | 2.02% | 102.90B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.76 | 0.83% | 126.64B | 16.69 | | RHHBY.PK | 41.96 | 1.23% | N/A | N/A | | AstraZeneca plc | AZN | 46.335 | 2.40% | 67.19B | 9.30 | | Abbott Laboratories | ABT | 54.27 | 0.06% | 83.94B | 14.70 | | Bristol-Myers Squibb Co. | BMY | 25.57 | 1.63% | 50.65B | 13.23 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | MRK | | Idera: Novartis deal ends, Merck pact extended
Wed 12:14pm -
AP | | • | MRK | | Three Reasons Merck's Time Has Come
Wed 10:05am -
at Minyanville.com | | • | GSK | | Human Genome Begins Trial
Wed 10:04am -
Zacks.com | | • | MRK | | Merck's Relief in Texas
Wed 7:58am -
Zacks.com | | • | GSK | | GlaxoSmithKline Seeks to Commercialize Viread in China for Hepatitis B
Wed 7:11am -
at Seeking Alpha | | • | MRK | | Merck Serono to Spend $225 Million on New Beijing R&D Center
Wed 7:09am -
at Seeking Alpha | | • | MRK | | The World's Best Dividend Stocks
Wed 7:00am -
at Motley Fool | | • | MRK | | [$$] Bears' Bets Up at NYSE, Nasdaq
Tue 7:19pm -
at The Wall Street Journal Online | | • | MRK | | Forgetful patients lift support consultancies
Tue 6:05pm -
at FT.com | | • | GSK | | [video] Topping the Tape
Tue 5:20pm -
at CNBC | | • | GSK | | How Big Pharma Profits from Swine Flu
Tue 3:37pm -
at BusinessWeek | | • | GSK | | Batch of swine flu vaccines studied in Canada
Tue 12:22pm -
AP | | • | GSK | | GlaxoSmithKline pulls swine flu vaccines in Canada
Tue 10:16am -
AP | | • | GSK | | Gilead signs sales deal with Glaxo for Viread
Tue 9:54am -
AP | | • | NVO | | The Complete List of Danish ADR Stocks
Fri, Nov 20 -
at Seeking Alpha | | • | NVO | | Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show
Thu, Nov 19 -
PR Newswire | | • | NVO | | Can This Stock Go Higher?
Wed, Nov 18 -
at Motley Fool | | • | NVO | | Secure Your Future Forever With These Stocks
Tue, Nov 17 -
at Motley Fool | | • | NVO | | Music to Health-Care Investors' Ears
Mon, Nov 16 -
at Motley Fool | | • | NVO | | International Healthcare Stock Picks From Natcan Investment Management
Mon, Nov 16 -
Wall Street Transcript | | | All Headlines for these symbols... |
|
|
|
0.25% Nasdaq 
Competitors
